Dr. Raghunathan is a Bioengineer in the Department of Surgical and Radiological Sciences at the University of California, Davis. He is cross trained in biomaterials, biomechanics, and cell and molecular biology with research interests and expertise in drug delivery, force microscopy, toxicology, tissue engineering and medical device development for orthopedic, wound healing, and ocular applications.
Dr. Russell is a Vision Scientist in the Department of Surgical and Radiological Sciences at the University of California, Davis. His research interests include glaucoma, aqueous humor dynamics, cataract and the influence of biophysical cues on ocular cells. He has studied the trabecular meshwork extensively and has human meshwork cells to test experimental drugs in vitro.
Dr. Nork is a founder, serves as a member of the Executive Board, and provides consulting on many aspects of vision science.
Dr. Nork is an Associate Professor of Ophthalmology at the University of Wisconsin School of Medicine and Public Health. He is fellowship trained in ophthalmic pathology, and his clinical specialties include diseases, surgery of the retina and vitreous, and clinical electrophysiology.
Dr. Miller is a Board Certified Veterinary Ophthalmologist and a Clinical Professor at the School of Veterinary Medicine, University of Wisconsin-Madison. His research and clinical interests focus on glaucoma in animals and, recently, he has worked extensively with non-human primate models of glaucoma.
Dr. Crosson serves as a member of the Executive Board and provides consulting on many aspects of vision science with a specific focus on pharmacology and animal models of elevated intraocular pressure, retinal degenerations and macular edema. Dr. Crosson is a Professor in the Department of Ophthalmology at the Medical University of South Carolina (MUSC). He is also Director of the Ola B. Williams Glaucoma Therapeutic Development Center and Senior Associate Dean for Research at MUSC. His research interests include ischemia, neovascularization, and neuroprotection.